Table 9.
Role of POT1 in different cancer types
| Human malignancy | POT1 expression levels | Suggested functional outcome | Ref |
|---|---|---|---|
| Breast cancer | Downregulation of POT1 mRNA | Dysregulation of telomerase activity | [264] |
| Colorectal cancer | Upregulation of POT1 mRNA and protein | [170, 265] | |
| Gastric cancer | Downregulation of POT1 mRNA in early cancer stage | Telomere dysfunction in early-stage cancer | [266] |
| Downregulation of POT1; expression decreases with disease severity | [256] | ||
| Glioblastoma | Downregulation of POT1 | Poorer prognosis | [267] |
| Hepatocellular carcinomas (HBV-related) | Upregulation of POT1 mRNA | Preserved 3′ overhang length, unlimited division of cancer cells, increased chromosomal instability | [175] |
| Downregulation of POT1 mRNA and protein | Poorer prognosis | [180–182] | |
| Splenic marginal zone lymphomas | Downregulation of POT1 | Increased chromosomal instability | [268] |
| Melanoma | Upregulation of POT1 | [269] | |
| Familial papillary thyroid cancer | Downregulation of POT1 as compared to sporadic cancers | [240] |